An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development-Reference-Cited by-同舟云学术

An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development

Author:

Retamozo Soledad¹²,Sisó-Almirall Antoni³⁴,Flores-Chávez Alejandra⁵,Ramos-Casals Manuel¹⁵^ORCID,Brito-Zerón Pilar⁵⁶

Affiliation:

1. Sjogren Syndrome Research Group (AGAUR), Department of Autoinmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain

2. Rheumatology Department, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain

3. Primary Care Centre Les Corts, Consorci d’Atenció Primària De Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain

4. Primary Healthcare Transversal Research Group, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain

5. Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain

6. Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA-Sanitas, Barcelona, Spain

Funder

funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

Reference105 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Sjögren’s disease;The Rose and Mackay Textbook of Autoimmune Diseases;2024

5. Síndrome de Sjögren;Medicina Clínica;2023-02